Add Company
Join Now

Foundation for Angelman Syndrome Therapeutics Revenue and Competitors

License our Company Data API

Location

N/A

Total Funding

Philanthropy

Industry

Employee Data

  • Foundation for Angelman Syndrome Therapeutics has 43 Employees.(i)
  • Foundation for Angelman Syndrome Therapeutics grew their employee count by 5% last year.

Foundation for Angelman Syndrome Therapeutics's People

NameTitleEmail/Phone
1
Chief Operating OfficerReveal Email/Phone
2
Chief Financial OfficerReveal Email/Phone
3
Science DirectorReveal Email/Phone
4
Meetings and Operations ManagerReveal Email/Phone
5
Development AdvisorReveal Email/Phone
6
Staff AccountantReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
N/A1-50%N/AN/A
#2
$75M477%N/AN/A
#3
N/A31-30%N/AN/A
#4
$7.5M1047%N/AN/A
#5
$7.5M58-5%N/AN/A
#6
$1.7M472%N/AN/A
#7
$3.5M21-5%N/AN/A
#8
$7.5M633%N/AN/A
#9
N/A336%N/AN/A
#10
$3.5M5213%N/AN/A
Add Company

What Is Foundation for Angelman Syndrome Therapeutics?

The Foundation for Angelman Syndrome Therapeutics (or FAST) is an organization of families and professionals dedicated to finding a cure for Angelman Syndrome and related disorders through the funding of an aggressive research agenda, education, and advocacy. The Foundation is committed to assisting individuals living with Angelman Syndrome to realize their full potential and quality of life. We are confident that our goals are now within reach and together, with your help, we will change lives. Now accepting grant applications for research directed at finding a cure for Angelman Syndrome. See http://www.cureangelman.org/cr.html for more details.

keywords:N/A

N/A

Total Funding

43

Number of Employees

N/A

Revenue (est)

5%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$7.2M4313%N/A
#2
N/A440%N/A
#3
$5.1M44-2%N/A
#4
$3.7M450%N/A
#5
$9.9M460%N/A